USA Financial Formulas’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-235
Closed -$21.7K 334
2024
Q4
$21.7K Sell
235
-408
-63% -$39.2K ﹤0.01% 267
2024
Q3
$59.7K Buy
+643
New +$55.7K 0.01% 211
2021
Q2
Sell
-5,656
Closed -$276K 412
2021
Q1
$276K Buy
+5,656
New +$265K 0.22% 112
2017
Q4
Sell
-15,516
Closed -$581K 309
2017
Q3
$581K Buy
+15,516
New +$528K 0.14% 143

Other funds holding LMAT

USA Financial Formulas's LMAT Position: Q1 2025 in Review

USA Financial Formulas sold out of LeMaitre Vascular (LMAT) in Q1 2025, closing a stake of 235 shares — an estimated $21.7K sold.

USA Financial Formulas first reported a position in LMAT in Q3 2017 and held it in 4 quarters. The position peaked at $581K in Q3 2017. 288 funds tracked by Wall St. Rank hold LMAT as of Q1 2025.

  • USA Financial Formulas reported no remaining LeMaitre Vascular position as of Q1 2025 after selling out during the quarter.
  • USA Financial Formulas sold 235 LeMaitre Vascular shares in Q1 2025, an estimated $21.7K.
  • USA Financial Formulas first reported a position in LeMaitre Vascular in Q3 2017 and held it in 4 quarters.
  • USA Financial Formulas's LeMaitre Vascular position peaked at $581K in Q3 2017.
  • 288 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2025.

Based on USA Financial Formulas's 13F filing for Q1 2025, filed 15 Apr 2025.